SFDA and the Saudi Medical Device Regulatory Framework

The Saudi Food and Drug Authority (SFDA) operates under the Saudi Medical Devices Regulation (SMDR), which was significantly updated and modernised in 2019 and further aligned with IMDRF principles in 2022. SFDA regulates the import, manufacture, distribution, and post-market surveillance of all medical devices in Saudi Arabia. All medical devices — from Class A (lowest risk) through Class D (highest risk) — must be SFDA registered before they can be imported, distributed, or sold in the Kingdom. Devices found on the Saudi market without valid SFDA registration are subject to confiscation and manufacturer/distributor sanctions.

SFDA Classification System

SFDA uses an IMDRF-aligned risk-based classification: Class A (low risk — sterile Class A and Class A measuring devices require Notified Body evidence), Class B (low-medium risk), Class C (medium-high risk), Class D (high risk). Classification aligns closely with EU MDR and IMDRF classification rules — a device's EU MDR class is typically a reliable starting point for SFDA classification, though manufacturers should verify Saudi-specific rules for their device category on the SFDA website.

Who Can Apply for SFDA Registration?

SFDA registration must be applied for by a Saudi-licensed Medical Device Establishment (MDE) — the Saudi-authorised representative of the manufacturer in the Kingdom. Foreign manufacturers cannot apply directly. The MDE must hold a valid Saudi establishment licence from SFDA, must be legally registered in Saudi Arabia, and must have a formal written agreement with the manufacturer designating them as the authorised Saudi representative. Selecting the right MDE is critical: the MDE's SFDA relationships, regulatory experience, and commercial network directly affect both registration success and market penetration.

Required Documents for SFDA Registration

The SFDA registration application requires: (1) Valid CE certificate under EU MDR or FDA 510(k)/PMA clearance — CE from an EU Notified Body is the most commonly used evidence; (2) Declaration of Conformity; (3) ISO 13485 certificate covering the device scope; (4) Device description and intended use in English and Arabic; (5) Labelling and IFU in Arabic (or bilingual Arabic/English — Arabic is mandatory); (6) Technical summary or performance data; (7) Free Sale Certificate issued by the competent authority in the manufacturer's home country (Turkey — obtainable from TITCK); (8) Letter of authorisation designating the Saudi MDE as authorised representative; (9) Any clinical study data or post-market surveillance summaries for higher-risk devices.

SFDA Registration Process: Step by Step

Step 1: Obtain or verify current CE certificate and ISO 13485 certificate. Step 2: Obtain a Free Sale Certificate from TITCK (Turkish Medicines and Medical Devices Agency) — allow 4–8 weeks. Step 3: Prepare Arabic-language labelling and IFU — engage a professional medical translator. Step 4: Select and formalise agreement with a Saudi MDE (licensed Saudi authorised representative). Step 5: MDE submits application through the GHAD (SFDA's online registration portal). Step 6: SFDA technical review — typically 3–9 months for Class B/C devices; Class A can be faster. Step 7: Any SFDA queries (deficiency letters) must be responded to within defined timeframes. Step 8: SFDA approval and registration number issued — valid for 5 years. Step 9: Annual compliance report submitted by MDE to maintain registration.

Arabic Labelling: A Non-Negotiable Requirement

Arabic labelling is mandatory for all medical devices sold in Saudi Arabia. The Arabic text must appear on both the device label and the Instructions for Use. Key labelling elements required in Arabic include: device name and description, manufacturer name and address, MDE name and address, intended purpose, warnings and precautions, storage conditions, expiry date, sterility information, and UDI. Arabic translation of medical device documentation requires a professional medical translator — machine translation is not acceptable for regulatory submissions. Errors in Arabic labelling are a common cause of SFDA deficiency letters and application delays.

Post-Registration Requirements

Once SFDA registration is obtained: the MDE must file an annual compliance report confirming the device's continued compliance; any changes to the device, manufacturer, labelling, or intended use must be reported to SFDA before implementation; serious adverse events must be reported within SFDA-defined timeframes; field safety corrective actions must be coordinated with SFDA; and the registration must be renewed every 5 years. SFDA conducts post-market surveillance inspections — having compliant documentation, batch records, and adverse event records is essential.

Conclusion

SFDA registration is a non-negotiable prerequisite for any Turkish medical device manufacturer targeting Saudi Arabia's substantial and growing market. The combination of CE marking, ISO 13485 certification, a TITCK Free Sale Certificate, Arabic labelling, and a strong Saudi MDE partner provides the foundation for a successful SFDA application. Turkish manufacturers who complete this process gain access to one of the world's fastest-growing healthcare markets and a platform for regional Middle East distribution through their Saudi MDE network.